Upfront autologous stem-cell transplantation with melphalan, cyclophosphamide, etoposide, and dexamethasone (LEED) in patients with newly diagnosed primary central nervous system lymphoma
Crossref DOI link: https://doi.org/10.1007/s12185-014-1608-9
Published Online: 2014-06-20
Published Print: 2014-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Miyao, Kotaro
Sakemura, Reona
Imai, Kanae
Sakai, Toshiyasu
Tsushita, Natsuko
Kato, Tomonori
Niimi, Keiko
Ono, Yoshitaka
Sawa, Masashi
Text and Data Mining valid from 2014-06-20